DoD prime vendor pilot project
First awards, expected the week of Nov. 30, have been delayed following a protest filed with the General Accounting Office by Norfolk, Va.-based wholesaler Renow. The project is designed to select a single drug and single medical device distributor for all Defense Department hospitals in a region, with awards targeted initially for the Washington, D.C. and Philadelphia-area regions and then the Tidewater, San Diego and San Francisco areas ("The Pink Sheet" Aug. 17, T&G-2). Renow is concerned that the prime vendor selections favor large wholesalers. GAO's deadline for its DoD prime vendor recommendation is March 8. While GAO's opinions are recommendations only, government agencies generally comply with them. Renow has operations in Pennsylvania, D.C., Virginia, North and South Carolina and Georgia.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth